WestRiver Group is an investment firm that offers integrated capital solutions to drive economic growth in enterprises.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
WestRiver Group is an investment firm that offers integrated capital solutions to drive economic growth in enterprises.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2022 | QorusDocs | Venture Round | 10M |
4/2020 | QorusDocs | Equity | 5M |
10/2022 | Talespin | Venture Round | - |
5/2019 | Madrona Venture Labs | Venture Round | 11.3M |
8/2019 | PTO Exchange | Seed Round | 3M |
3/2021 | Tradeshift | Convertible Note | 0 |
2/2019 | Tectonic | Series B | 6M |
5/2009 | DocuSign | Series B | 5M |
4/2022 | Tagboard | Series A | 0 |
12/2007 | Cardiac Dimensions | Series D | 0 |
5/2007 | Catalist Homes | Series D | 4.5M |
8/2009 | SMITH (formerly Ascentium) | Venture Round | - |
3/2020 | Wicket Labs | Venture Round | 0 |
1/2008 | Entellium | Series C | 10M |
7/2018 | Wicket Labs | Seed Round | 0 |
1/2021 | CHEQ | Pre Seed Round | 5.5M |
12/2018 | The Riveter | Series A | 0 |
3/2022 | PTO Exchange | Seed | 5.4M |
10/2022 | Viome | Series C | 67M |
4/2012 | Symform | Series B | 0 |
6/2005 | Tachyon Networks | Series C | 0 |
9/2003 | Tachyon Networks | Series B | 0 |
10/2019 | TOCA Football | Series D | 0 |
9/2020 | Lumen Bioscience | Series B | 0 |
1/2021 | Usermind | Series C | 0 |
1/2019 | Pro.com | Series B | 33M |
9/2007 | DocuSign | Series B | 12.4M |
2/2020 | Plume Design | Debt Financing | 25M |
5/2018 | Viewpath | Seed Round | 2.3M |
3/2020 | Design Therapeutics | Series A | 45.5M |
1/2023 | Colossal Biosciences | Series B | 150M |
9/2022 | CHEQ | Seed Round | 8M |
6/2021 | TOCA Football | Series E | 0 |
6/2022 | Alladapt Immunotherapeutics | Venture Round | 0 |
6/2019 | ONEHOPE | Convertible Note | 6M |
2/2018 | Singularity University | Series B | 32M |
3/2019 | Igneous | Series C | 25.9M |
11/2021 | Viome | Series C | 0 |
1/2005 | Alexza Pharmaceuticals | Series D | 0 |
4/2004 | Corus Pharma | Series C | 0 |
12/2016 | Play Impossible | Seed Round | 1.4M |
1/2021 | Design Therapeutics | Series B | 125M |
6/2022 | Alladapt Immunotherapeutics | Venture Round | 0 |
4/2022 | Tagboard | Series A | 0 |
3/2022 | PTO Exchange | Seed Round | 0 |
11/2021 | Viome | Series C | 0 |
6/2021 | TOCA Football | Series E | 0 |
3/2021 | Tradeshift | Convertible Note | 0 |
1/2021 | Design Therapeutics | Series B | 0 |
1/2021 | Usermind | Series C | 0 |
9/2020 | Lumen Bioscience | Series B | 0 |
4/2020 | QorusDocs | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|